发明名称 |
SUSTAINED-RELEASE FORMULATION FOR INJECTION |
摘要 |
The present invention relates to a composition comprising N-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]-(2R,3R)-2,3-tetramethylene-butyl]-(1'R,2'S,3'R,4'S)-2,3-bicyclo[2,2,1]heptanedicarboximide or a pharmaceutically acceptable acid addition salt thereof. In detail, the composition relates to a sustained release formulation for injection which maintains an effective blood level of the above-mentioned compound. |
申请公布号 |
WO2012053654(A1) |
申请公布日期 |
2012.04.26 |
申请号 |
WO2011JP74375 |
申请日期 |
2011.10.18 |
申请人 |
DAINIPPON SUMITOMO PHARMA CO., LTD.;NAKAGAWA, TAKASHI;KOSEKI, NORIMASA |
发明人 |
NAKAGAWA, TAKASHI;KOSEKI, NORIMASA |
分类号 |
A61K31/496;A61K9/08;A61K47/12;A61K47/16;A61K47/20;A61K47/34;C07D417/12 |
主分类号 |
A61K31/496 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|